Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-26 @ 12:45 AM
Study NCT ID:
NCT00403260
Status:
COMPLETED
Last Update Posted:
2021-11-02
First Post:
2006-11-22
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Pyronaridine - Artesunate (3:1) Versus Mefloquine Plus Artesunate in Plasmodium Falciparum Malaria Patients
Sponsor:
Medicines for Malaria Venture
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-01
Start Date Type:
ACTUAL
Primary Completion Date:
2008-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-12
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-22
First Submit QC Date:
None
Study First Post Date:
2006-11-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-08-20
Results First Submit QC Date:
None
Results First Post Date:
2021-09-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-22
Last Update Post Date:
2021-11-02
Last Update Post Date Type:
ACTUAL